Ex vivo generation of interstitial and Langerhans cell-like dendritic cell subset-based vaccines for hematological malignancies.

Abstract

Autologous, patient-specific, monocyte-derived dendritic cell (MoDC) vaccines have been successfully applied in the clinical studies so far. However, the routine application of this strategy has been hampered by the difficulties in generating sufficient numbers of DC and the poor DC vaccine quality because of pathology or prior treatment received by the patients. The immunotherapeutic potential of other subsets of DC has not been thoroughly investigated because of their rarity in tissues and difficulties associated with their ex vivo generation. The high expansion and differentiation potential of CD34 hematopoietic progenitor cells (HPC), isolated from umbilical cord blood (UCB), into different DC subsets make them an attractive alternative DC source for cancer immunotherapy. Therefore, the aim of this study was to generate a large number of different DC subsets from CD34 HPC and evaluate their functionality in comparison with MoDC. Our culture protocol generated a clinically relevant number of mature CD1a myeloid DC and CD207 Langerhans cells (LC)-like DC subsets from CD34 HPC with >95% purity. Both DC subsets exhibited a cytokine profile that favors cytotoxic T-cell responses. Furthermore, UCB-DC and UCB-LC demonstrated superior induction of proliferation of both allogeneic as well as viral antigen-specific CD8 T cells, both in vitro and in vivo. Additional studies revealed that UCC-DC and UCB-LC can efficiently expand minor histocompatibility antigen (MiHA) HA-1-specific cytotoxic T cells in the peripheral blood of leukemia patients and prime MiHA HA-1-specific and HA-2-specific cytotoxic T cells in vitro. These preclinical findings support the pharmaceutical development of the described culture protocol for clinical evaluation.

• Authors: Tim Hutten, Soley Thordardottir, Willemijn Hobo, Jessica Hübel, Anniek B van der Waart, Jeannette Cany, Harry Dolstra, Basav N Hangalapura
• Journal: Journal of immunotherapy (Hagerstown, Md. : 1997) (J Immunother) Vol. 37 Issue 5 Pg. 267-77 (Jun 2014) ISSN: 1537-4513 [Electronic] United States
• PMID: 24810638 (Publication Type: Comparative Study, Journal Article)

Chemical References

• Antigens, CD
• Cancer Vaccines
• Cytokines
• Minor Histocompatibility Antigens

Topics

• Antigens, CD (metabolism)
• Cancer Vaccines
• Cell Differentiation
• Cell Proliferation
• Cells, Cultured
• Cytokines (metabolism)
• Dendritic Cells (physiology, transplantation)
• Hematologic Neoplasms (immunology, therapy)
• Hematopoietic Stem Cells (physiology)
• Humans
• Immunotherapy (methods)
• Lymphocyte Activation
• Minor Histocompatibility Antigens (immunology)
• Monocytes (physiology)
• T-Lymphocytes, Cytotoxic (immunology)